SCHEMBL27835239

SCHEMBL27835239

COc1ccccc1-c1nc(Cl)nc(Nc2cccc(Br)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.51
MAPT P10636 3/20 0.47
KDM4E B2RXH2 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PTK2 Q05397 1/20 0.45
NFKB1 P19838 2/20 0.45
APP P05067 1/20 0.45
EGFR P00533 6/20 0.45
ABCB1 P08183 1/20 0.44
ABCC1 P33527 1/20 0.44
TNF P01375 1/20 0.44
AGPAT2 O15120 1/20 0.44
FBP1 P09467 2/20 0.43
THRB P10828 1/20 0.43
GAK O14976 2/20 0.41
ABL1 P00519 2/20 0.41
MAPK1 P28482 2/20 0.41
KDR P35968 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27835194 0.86 MAPT (0.57) MAPTKDM4EKMT2AALDH1A1SMN1; SMN2
SCHEMBL27815788 0.81 ABCG2 (0.64) ABCG2MAPTKDM4EKMT2AALDH1A1
SCHEMBL27815707 0.80 VCP (0.52) MAPTKDM4EKMT2AALDH1A1SMN1; SMN2
SCHEMBL1592702 0.79 ABCG2 (0.57) ABCG2MAPTSMN1; SMN2NFKB1APP
SCHEMBL8978637 0.78 NFKB1 (0.65) ABCG2MAPTKMT2AALDH1A1NFKB1
SCHEMBL11405229 0.75 ALDH1A1 (0.52) MAPTKDM4EKMT2AALDH1A1SMN1; SMN2
SCHEMBL30490523 0.72 NFKB1 (0.53) MAPTKMT2ANFKB1EGFRAGPAT2
SCHEMBL29609042 0.71 NFKB1 (0.64) MAPTKMT2ASMN1; SMN2NFKB1APP
SCHEMBL13326017 0.71 NFKB1 (0.64) MAPTKMT2ASMN1; SMN2NFKB1APP
SCHEMBL7564951 0.70 KDR (0.58) ABCG2EGFRABCB1ABCC1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102143953-A Pyrimidines, triazines and their use as pharmaceutical agents UNIV NOTTINGHAM 2011-08-03 CN disclosed